ホーム
探索
nav.journalClub
トレンド
その他
synapse
⌘+K
言語
日本語
日本語
Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy | Synapse
March 3, 2026
Clinical effort against smoke exposure in cystic fibrosis (CEASE-CF): feasibility, acceptability, and preliminary efficacy
GO
Gabriela R. Oates
University of Alabama at Birmingham
RG
R. Geurs
University of Alabama at Birmingham
CM
Cathy Mims
See all
Key Points
The clinical intervention shows promising acceptability among participants with cystic fibrosis, suggesting a positive response.
Preliminary efficacy results indicate improvements in measured biomarkers related to smoke exposure effects.
Feasibility assessed in a multi-site analysis under various conditions, focusing on practical implementation.
Indicates a need for larger trials to confirm the efficacy and long-term benefits of the intervention for cystic fibrosis.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Oates et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d45c6e9836116a2703e
https://doi.org/https://doi.org/10.1016/j.jcf.2026.01.007